Covid antiviral pill mollupiravir/Legavio set for home trials in UK

The first home remedy for COVID-19 could reportedly be offered to UK patients ahead of Christmas as an effort to protect the most vulnerable from the Omicron version.

The Sunday Telegraph reports that Sajid Javid is set to launch a national pilot Molnupiravir antiviral pill, marketed as Lagevario,

The newspaper said that under the plans, the NHS is expected to distribute courses of tablets to clinically vulnerable and immunosuppressed patients within 48 hours of testing positive for Covid.

It said hospitals and GPs were told that a series of COVID drug delivery units were being set up to ensure that patients get treatment as soon as it is confirmed that they have the virus. Is.

Last month, the UK became the first country in the world to license its use – a move described by Health Secretary Javid as a “gamechanger”.

But just a week ago, England’s chief medical officer, Prof Chris Whitty, warned that its use may need to be reconsidered in light of the emergence of Omicron. “I think we probably need to rethink this with the new version to make sure we’re aiming in the right direction.”

A spokesman for the Department of Health and Social Care said: “The UK has proven itself to be a world leader in identifying and introducing effective treatments for COVID-19, including government-backed national trials.

“The Government’s Antiviral Taskforce was launched to identify treatments for UK patients who have been exposed to COVID-19 to take home, prevent the spread of infection and speed up recovery. bring.

“There are many exciting opportunities in the pipeline and we will provide more details in due course.”